A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

Clinical trial NCT00099177 · TERMINATED

Trial details

NCT number: NCT00099177
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pain Bone Neoplasm Neoplasm Metastasis

Start date: 2005-08-01
Primary completion: 2007-12-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.